The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 16, 2020

Filed:

Mar. 22, 2013
Applicants:

Ensuiko Sugar Refining Co., Ltd., Tokyo, JP;

Hiroki Hamada, Okayama, JP;

Ichiro Fujiwara, Okayama, JP;

National University Corporation Okayama University, Okayama-shi, Okayama, JP;

Inventors:

Hiroki Hamada, Okayama, JP;

Ichiro Fujiwara, Okayama, JP;

Masaharu Seno, Okayama, JP;

Tomonari Kasai, Okayama, JP;

Tsukasa Shigehiro, Okayama, JP;

Masaharu Murakami, Okayama, JP;

Katsuhiko Mikuni, Kanagawa, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/337 (2006.01); A61K 47/26 (2006.01); A61K 9/127 (2006.01); A61K 31/7048 (2006.01); C07K 16/32 (2006.01); A61K 47/69 (2017.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/337 (2013.01); A61K 9/127 (2013.01); A61K 31/7048 (2013.01); A61K 47/6913 (2017.08); C07K 16/32 (2013.01); A61K 2039/505 (2013.01); C07K 2317/24 (2013.01); C07K 2317/73 (2013.01);
Abstract

In order to reduce the side effects of paclitaxel derivatives having excellent anti-cancer effects, an attempt was made to produce a liposome encapsulating paclitaxel derivatives such as paclitaxel monoglycosides and docetaxel monoglycosides. However, the introduction efficiency of paclitaxel derivatives, etc., into a liposome was poor, and this technique was not developed to a practical level. The present invention provides a method for producing a liposome encapsulating a paclitaxel monoglycoside and/or a docetaxel monoglycoside, and having an antibody specifically recognizing a cancer cell, the method comprising a step of bringing a liposome encapsulating a polyoxyethylene ester derivative, a lower alcohol, and a buffer or water into contact with a solution in which a paclitaxel monoglycoside and/or a docetaxel monoglycoside is dissolved in an alkylene glycol-containing buffer or water.


Find Patent Forward Citations

Loading…